Metastatic Infiltration of Anaplastic Carcinoma of the Pancreas Into the Portal Venous System: A Masquerading Cause of Expansive Portal Venous Thrombosis

Yuka Hirakawa; Masaki Tago; Naoko E. Katsuki; Seijiro Makio; Shu-ichi Yamashita

doi:10.12659/AJCR.929678

26 March 2021: Articles

Metastatic Infiltration of Anaplastic Carcinoma of the Pancreas Into the Portal Venous System: A Masquerading Cause of Expansive Portal Venous Thrombosis

Challenging differential diagnosis

Yuka Hirakawa ^A , Masaki Tago ^A* , Naoko E. Katsuki ^A , Seijiro Makio ^A , Shu-ichi Yamashita ^A

DOI: 10.12659/AJCR.929678

Am J Case Rep 2021; 22:e929678

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Figure 3. Positron emission tomography-computed tomography (PET-CT) performed in the 3rd month after the first assessment. (A) High uptake of fluorodeoxyglucose is seen in the intrahepatic portal veins (arrows) in PET-CT images at the level of the liver. The standardized uptake value (SUV) max was 4.94 in the early phase and 5.25 in the delayed phase. (B) High uptake of fluorodeoxyglucose is revealed in the splenic vein (arrow) in the PET-CT image at the level of the pancreas.

Back to the Article

Metastatic Infiltration of Anaplastic Carcinoma of the Pancreas Into the Portal Venous System: A Masquerading Cause of Expansive Portal Venous Thrombosis

Your Privacy